Open AccessComparison of a histone deacetylase inhibitor plus exemestane with exemestane alone in hormone receptor‑positive advanced breast cancer that progressed on prior endocrine therapy: A meta‑analysis
Author(s) -
Liang Xu,
Weifan Jiang,
Wenwei Li,
Chungen Guo,
Lihua Luo,
Yufeng Gao,
Yali Cao
Publication year - 2022
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2022.11512
Subject(s) - exemestane , breast cancer , histone deacetylase inhibitor , medicine , estrogen receptor , oncology , histone deacetylase , cancer , tamoxifen , aromatase inhibitor , fulvestrant , combination therapy , epigenetics , hazard ratio , cancer research , histone , biology , confidence interval , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom